Main > TRANSPLANTATION (Cells, Organs Etc) > Rejection. > Treatment > Oxazole. Deriv

Product DE. A

PATENT ASSIGNEE'S COUNTRY Germany
UPDATE 10.00
PATENT ASSIGNEE Aventis Pharma Deutschland GmbH
PATENT CLAIMS 1,2-Oxazole-4-(CO-NH-C6H4-CF3)-5-Me
PATENT PHOTOCOPY Available on request

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back